Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.24.2.u1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue:        
Product revenue, net $ 14,855 $ 16,961 $ 27,885 $ 29,126
Other revenue   211   259
Total revenue 14,855 17,172 27,885 29,385
Operating expenses        
Cost of goods sold - product revenue 6,541 7,767 13,357 14,216
Research and development 913 1,774 8,797 3,807
Selling, general and administrative 10,328 12,141 18,748 25,433
Loss on impairment of intangible assets   3,143   3,143
Total operating expenses 17,782 24,825 40,902 46,599
Loss from operations (2,927) (7,653) (13,017) (17,214)
Other expense (income)        
Interest income (161) (79) (378) (201)
Interest expense 563 756 1,111 1,406
Foreign exchange transaction losses 32 33 53 80
Total other expense (income) 434 710 786 1,285
Loss before income taxes (3,361) (8,363) (13,803) (18,499)
Net loss $ (3,361) $ (8,363) $ (13,803) $ (18,499)
Net loss per common share:        
Basic $ (0.17) $ (0.46) $ (0.69) $ (1.03)
Diluted $ (0.17) $ (0.46) $ (0.69) $ (1.03)
Weighted average number of common shares:        
Basic 19,993,858 18,005,055 19,875,653 17,906,671
Diluted 19,993,858 18,005,055 19,875,653 17,906,671